247 related articles for article (PubMed ID: 29784747)
1. New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma.
Barker CA; Salama AK
J Natl Compr Canc Netw; 2018 May; 16(5S):646-650. PubMed ID: 29784747
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.
Rao PK; Barker C; Coit DG; Joseph RW; Materin M; Rengan R; Sosman J; Thompson JA; Albertini MR; Boland G; Carson Iii WE; Contreras C; Daniels GA; DiMaio D; Durham A; Fields RC; Fleming MD; Galan A; Gastman B; Grossman K; Guild V; Johnson D; Karakousis G; Lange JR; ; Margolin K; Nath S; Olszanski AJ; Ott PA; Ross MI; Salama AK; Skitzki J; Swetter SM; Wuthrick E; McMillian NR; Engh A
J Natl Compr Canc Netw; 2020 Feb; 18(2):120-131. PubMed ID: 32023525
[TBL] [Abstract][Full Text] [Related]
3. The newest treatments for uveal melanoma.
Luke JJ
Clin Adv Hematol Oncol; 2019 Sep; 17(9):490-493. PubMed ID: 31549969
[No Abstract] [Full Text] [Related]
4. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
[No Abstract] [Full Text] [Related]
5. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
6. Obstacles to improving outcomes in the treatment of uveal melanoma.
Tsai KK; Bollin KB; Patel SP
Cancer; 2018 Jul; 124(13):2693-2703. PubMed ID: 29579316
[TBL] [Abstract][Full Text] [Related]
7. [THE BRAF MUTATION AND THE POSSIBILITIES OF UVEAL MELANOMA METASTASING PROGNOSTIC MARKERS IDENTIFICATION].
Horkovičová K; Markus J; Krčová I; Babál P; Kobzová D; Smolková B
Cesk Slov Oftalmol; 2016; 72(4):149-156. PubMed ID: 27860480
[TBL] [Abstract][Full Text] [Related]
8. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Gurski L; Freedman-Cass DA
J Natl Compr Canc Netw; 2018 Jul; 16(7):874-901. PubMed ID: 30006429
[TBL] [Abstract][Full Text] [Related]
9. Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
McKean MA; Amaria RN
Am J Clin Dermatol; 2018 Oct; 19(5):639-646. PubMed ID: 30039289
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival Melanoma: Current Treatments and Future Options.
Grimes JM; Shah NV; Samie FH; Carvajal RD; Marr BP
Am J Clin Dermatol; 2020 Jun; 21(3):371-381. PubMed ID: 31965542
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.
Levine O; Devji T; Xie F
Immunotherapy; 2017 Mar; 9(5):375-378. PubMed ID: 28357918
[No Abstract] [Full Text] [Related]
12. Treatment options expanding for advanced melanoma.
Thompson JA
J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):673-5. PubMed ID: 25995427
[TBL] [Abstract][Full Text] [Related]
13. Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma.
Alexander M; Mellor JD; McArthur G; Kee D
Med J Aust; 2014 Jul; 201(1):49-53. PubMed ID: 24999899
[TBL] [Abstract][Full Text] [Related]
14. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract][Full Text] [Related]
15. NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Hahn N; Herr HW; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Meeks JJ; Michalski J; Montgomery JS; Pagliaro LC; Pal SK; Patterson A; Petrylak DP; Plimack ER; Pohar KS; Porter MP; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wile G; Johnson-Chilla A; Dwyer MA; Gurski LA
J Natl Compr Canc Netw; 2018 Sep; 16(9):1041-1053. PubMed ID: 30181416
[TBL] [Abstract][Full Text] [Related]
16. Uveal Melanoma UK National Guidelines.
Nathan P; Cohen V; Coupland S; Curtis K; Damato B; Evans J; Fenwick S; Kirkpatrick L; Li O; Marshall E; McGuirk K; Ottensmeier C; Pearce N; Salvi S; Stedman B; Szlosarek P; Turnbull N;
Eur J Cancer; 2015 Nov; 51(16):2404-12. PubMed ID: 26278648
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
Komatsubara KM; Carvajal RD
Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938
[TBL] [Abstract][Full Text] [Related]
18. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Haddad RI; Nasr C; Bischoff L; Busaidy NL; Byrd D; Callender G; Dickson P; Duh QY; Ehya H; Goldner W; Haymart M; Hoh C; Hunt JP; Iagaru A; Kandeel F; Kopp P; Lamonica DM; McIver B; Raeburn CD; Ridge JA; Ringel MD; Scheri RP; Shah JP; Sippel R; Smallridge RC; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Johnson-Chilla A; Hoffmann KG; Gurski LA
J Natl Compr Canc Netw; 2018 Dec; 16(12):1429-1440. PubMed ID: 30545990
[TBL] [Abstract][Full Text] [Related]
19. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
20. [Uveal melanoma in patients with ocular or oculodermal melanocytosis].
Szuścik I; Romanowska-Dixon B; Jakubowska B; Orłowska-Heitzman J
Klin Oczna; 2008; 110(10-12):380-3. PubMed ID: 19195171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
